GLOW 70MG

GLOW peptide is a compounded, 3-peptide research blend consisting of GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 (10 mg) totaling 70mg of concentration in a standard 3ml size vial. It is distinct from the 4-peptide “KLOW” stack by the removal of KPV and instead more focused on the regenerative properties that GLOW is classically known for. GLOW emerges as the right choice for research focused on structural repair without an inflammatory component.

Practical reasons someone would pick GLOW over KLOW:

• Skin-first goal, no active inflammation. If the priority is firmness, fine lines, texture, or post-procedure skin remodeling and the inflammatory picture is minimal, GLOW’s higher relative GHK-Cu load is the more targeted choice.

• Cost. GLOW typically runs ~$145/vial vs. ~$160 for KLOW; the ~$15–50 premium for KLOW is only justified when KPV’s NF-κB anti-inflammatory pathway is actually needed.

• Simplicity. Fewer components, fewer variables — easier to attribute effects to a specific peptide in a research or aesthetic protocol.

• Aesthetic clinic positioning. Some practitioners (e.g., plastic surgeons) reserve GLOW for facial work where the inflammatory field is small and incision quality/skin quality is the priority, saving KLOW for larger body procedures with more tissue trauma and inflammation.

In short: GLOW when the job is structural repair and collagen signaling; KLOW when that same repair is happening in an actively inflamed or immune-challenged environment.